Omeprazole Eg (Omeprazole)

Omeprazole Eg is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related conditions:

• Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and promotes healing of the esophageal lining.
• Peptic ulcer disease: supports ulcer healing and reduces recurrence risk.
• Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with this rare tumor.
• Helicobacter pylori eradication regimens: used in combination with antibiotics to improve eradication rates.

• Omeprazole selectively inhibits the H+/K+‑ATPase enzyme (the gastric proton pump) located on the secretory surface of parietal cells. By binding covalently to the pump’s cysteine residues, it blocks the final step of acid secretion, leading to a sustained increase in gastric pH and reduced acidity in the stomach.

Omeprazole may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects

• Headache: mild, transient headache reported in many patients.
• Diarrhea: loose stools that usually resolve without intervention.
• Nausea: occasional feeling of queasiness.
• Abdominal pain: mild discomfort in the stomach area.
• Flatulence: increased gas production.
• Constipation: reduced bowel movements.

Serious or Rare Side Effects

• Clostridioides difficile infection: severe colitis associated with antibiotic‑related dysbiosis.
• Hypomagnesemia: low magnesium levels that may cause muscle cramps or cardiac arrhythmia.
• Fracture risk: long‑term use linked to decreased bone mineral density.
• Acute interstitial nephritis: inflammation of kidney interstitium.
• Stevens‑Johnson syndrome: rare severe skin reaction.
• Hepatotoxicity: elevated liver enzymes indicating liver stress.

When prescribing Omeprazole Eg, clinicians should consider several safety aspects:

• Assess renal function: adjust use in patients with severe kidney impairment.
• Monitor magnesium levels: long‑term therapy may deplete magnesium.
• Evaluate bone health: consider calcium/vitamin D supplementation for prolonged use.
• Review concomitant medications: potential for altered absorption of drugs requiring acidic pH.
• Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment.
• Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Omeprazole Eg can affect the pharmacokinetics of several co‑administered medicines.

Major Interactions (Avoid)

• Clopidogrel: reduced antiplatelet effect, may increase cardiovascular risk.
• Atazanavir: decreased absorption leading to therapeutic failure.
• Ketoconazole: markedly reduced antifungal exposure.

Moderate Interactions (Monitor Closely)

• Warfarin: potential increase in INR, requiring more frequent monitoring.
• Digoxin: higher serum concentrations may occur.
• Methotrexate: reduced renal clearance can raise toxicity risk.